Founded by serial entrepreneur Dinakara Nagalla, the platform enters the Indian market with 30,000 users, and 500 wellbeing professionals
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
New facility will open by October 2026 and house 500 process development specialists
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
